Insider Transactions in Q1 2016 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q1 2016)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2016
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,537
+10.17%
|
$126,850
$50.77 P/Share
|
|
Feb 22
2016
|
Willie A Deese Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
14,557
+9.81%
|
$727,850
$50.77 P/Share
|
|
Feb 22
2016
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
11,332
+32.46%
|
$566,600
$50.77 P/Share
|
|
Feb 22
2016
|
Kenneth C Frazier Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
93,241
+15.14%
|
$4,662,050
$50.77 P/Share
|
|
Feb 22
2016
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,377
+8.58%
|
$168,850
$50.77 P/Share
|
|
Feb 22
2016
|
Clark Golestani EVP & Chief Info Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,150
+25.14%
|
$307,500
$50.77 P/Share
|
|
Feb 22
2016
|
Weir Mirian M Graddick Exe V-P, HR |
BUY
Grant, award, or other acquisition
|
Direct |
16,326
+11.08%
|
$816,300
$50.77 P/Share
|
|
Feb 22
2016
|
Michael J Holston EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,443
+15.15%
|
$572,150
$50.77 P/Share
|
|
Feb 22
2016
|
Michael Rosenblatt Exec V-P & Chief Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,738
+15.83%
|
$386,900
$50.77 P/Share
|
|
Feb 22
2016
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Grant, award, or other acquisition
|
Direct |
37,223
+50.0%
|
$1,861,150
$50.77 P/Share
|
|
Feb 22
2016
|
Roger M Perlmutter Exe V-P & Pres, MRL |
BUY
Grant, award, or other acquisition
|
Direct |
25,227
+33.43%
|
$1,261,350
$50.77 P/Share
|